Risk factors and management of breast cancer-related lymphedema

  • Authors

    • Awad Alawad University of Medical Sciences and Technology
    • Ayat Omer Ibrahim
    2015-04-17
    https://doi.org/10.14419/ijm.v3i1.4471
  • Lymphedema, Risk Factors, Breast Cancer.

  • Background: Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life.

    Objective: The aim of this study was to identify the clinical presentation of lymphedema associated factors in women treated for breast cancer.

    Methods:The study is an interventional prospective study. It was accomplished in the period from May 2013 to April 2014. Patients having breast cancer ipsilateral arm lymphedema were selected for the study.

    Results: A total of 34 patients were included in the study.73.5% of patients have a body mass index (BMI) of 25 or more at diagnosis. 70.6% of the patients underwent axillary clearance. All the patients did not undergo breast reconstruction. 52.4% had <10 lymph nodes removed from their axillae. 47% received radiotherapy. All patients presented with arm swelling, additionally, 70.6 % presented with arm heaviness 26.5% presented with arm pain. Elevation was effective in 90.5% of the compliant patients, while exercise was effective in 84.2% of the compliant patients.

    Conclusion: Breast cancer- related lymphedema continues to be a significant problem following breast cancer therapy. Presence of co-morbid conditions axillary radiation significantly increases the risk of lymphedema. A combination of axillary dissection axillary radiation should be avoided whenever feasible to avoid lymphedema.

  • References

    1. [1] Ahmed, A. A. M. (2014). Clinicopathological profile of female Sudanese patients with locally advanced breast cancer. Breast disease, 34(3), 131-134. http://dx.doi.org/10.3233/BD-140363.

      [2] Alawad, A., Alshiekh, A., & Alhaj, A. (2014). Demographic Characteristics and Review of Patients with Locally Advanced Breast Cancer in Sudan. Afrimedic Journal, 4(2), 5-8.

      [3] Alawad, A. A. M. (2014). Evaluation of clinical and pathological response after two cycles of neoadjuvant chemotherapy on sudanese patients with locally advanced breast cancer. Ethiopian journal of health sciences, 24(1), 15-20. http://dx.doi.org/10.4314/ejhs.v24i1.2.

      [4] Campisi, C. (2002). [Surgery of breast cancer, secondary lymphedema and quality of life: a challenge for the general surgeon]. Ann Ital Chir, 73(5), 471.

      [5] Goffman, T. E., Laronga, C., Wilson, L., & Elkins, D. (2004). Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J, 10(5), 405-411. http://dx.doi.org/10.1111/j.1075-122X.2004.21411.x.

      [6] Han, J. W., Seo, Y. J., Choi, J. E., Kang, S. H., Bae, Y. K., & Lee, S. J. (2012). The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer. J Breast Cancer, 15(1), 91-97. http://dx.doi.org/10.4048/jbc.2012.15.1.91.

      [7] Kosir, M. A., Rymal, C., Koppolu, P., Hryniuk, L., Darga, L., Du, W., et al. (2001). Surgical outcomes after breast cancer surgery: measuring acute lymphedema. J Surg Res, 95(2), 147-151. http://dx.doi.org/10.1006/jsre.2000.6021.

      [8] Lopez Penha, T. R., Voogd, A. C., Heuts, E. M., Ijsbrandy, C., Hendrix, N. A., von Meyenfeldt, M. F., et al. (2014). Reduced prevalence of lymphedema in patients with reconstructive breast surgery. Breast J, 20(6), 671-673. http://dx.doi.org/10.1111/tbj.12342.

      [9] Lu, S. R., Hong, R. B., Chou, W., & Hsiao, P. C. (2015). Role of physiotherapy and patient education in lymphedema control following breast cancer surgery. Ther Clin Risk Manag, 11, 319-327.

      [10] Marcos, A. L., El Gaaied, A. B., Ayed, F. B., Hassen, S. B., Zervoudis, S., Navrozoglou, I., et al. (2012). Lymphedema of the arm after surgery for breast cancer: new physiotherapy. Clin Exp Obstet Gynecol, 39(4), 483-488.

      [11] Monleon, S., Murta-Nascimento, C., Bascuas, I., Macia, F., Duarte, E., & Belmonte, R. (2014). Lymphedema Predictor Factors after Breast Cancer Surgery: A Survival Analysis. Lymphat Res Biol. http://dx.doi.org/10.1089/lrb.2013.0042.

      [12] Soran, A., Wu, W. C., Dirican, A., Johnson, R., Andacoglu, O., & Wilson, J. (2011). Estimating the probability of lymphedema after breast cancer surgery. Am J Clin Oncol, 34(5), 506-510.

      [13] van der Veen, P., De Voogdt, N., Lievens, P., Duquet, W., Lamote, J., & Sacre, R. (2004). Lymphedema development following breast cancer surgery with full axillary resection. Lymphology, 37(4), 206-208.

      [14] Vignes, S., Arrault, M., & Ebelin, M. (2006). [Poor influence of surgery on upper limb lymphedema volume in patients after breast cancer treatment]. J Mal Vasc, 31(4 Pt 1), 202-205. http://dx.doi.org/10.1016/S0398-0499(06)76544-1.

  • Downloads

  • How to Cite

    Alawad, A., & Ibrahim, A. O. (2015). Risk factors and management of breast cancer-related lymphedema. International Journal of Medicine, 3(1), 38-40. https://doi.org/10.14419/ijm.v3i1.4471